Biliary Stents Market – By Type, By Application, By End Use, Global Forecast, 2025 – 2034

Biliary Stents Market Size

The global biliary stents market size was valued at USD 455.3 million in 2024 and is expected to exhibit growth at a CAGR of 5.2% from 2025 to 2034. The significant market growth can be attributed to the increasing prevalence of bile duct and chronic liver diseases, along with technological advancements in stents.
 

Biliary stents are commonly used in minimally invasive endoscopic and interventional radiology procedures, which are increasingly preferred due to their shorter recovery times and lower risk of complications. Procedures like endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) are highly precise, reducing patient risks.
 

Furthermore, the rise in biliary diseases such as cholangitis, biliary strictures, and pancreatic cancers is a key driver of the demand for biliary stents. Pancreatic and liver cancers often result in bile duct obstructions, which require biliary stents for palliative care and symptom management. Additionally, conditions such as chronic pancreatitis and post-surgical biliary strictures also necessitate stenting to restore bile flow. The growing global burden of these diseases, driven by unhealthy lifestyle habits and aging populations, is significantly fueling market demand.
 

Biliary stents are small, tubular devices used to treat blockages or obstructions in the bile ducts. They are employed in managing conditions such as biliary strictures, biliary leaks, or cholangitis, which are often associated with pancreatic or liver diseases, including cancer.
 

Biliary Stents Market Trends

The increasing preference for minimally invasive procedures in healthcare, including percutaneous transhepatic cholangiography (PTC) and endoscopic retrograde cholangiopancreatography (ERCP), is driving the demand for biliary stents.
 

• The development of advanced materials has greatly enhanced the functionality and durability of biliary stents. Nitinol, a shape-memory alloy, is commonly used in modern stents due to its flexibility, strength, and ability to expand upon placement without deforming. Additionally, the use of biocompatible polymers such as polyethylene and polyurethane in plastic stents is improving their effectiveness, particularly in preventing clogging and maintaining patency over time.
   
• Furthermore, advancements in imaging technologies, such as 3D imaging and computer-assisted design (CAD), are enabling the creation of customized biliary stents tailored to individual patient anatomies. This innovation improves stent placement accuracy, reduces complications, and increases the overall success rate of stent procedures.
   

Biliary Stents Market Analysis

Based on type, the market is classified into metal stents and polymer stents. The metal stents segment generated the highest revenue of USD 292.8 million in 2024.
 

• Innovative designs, such as fully covered and partially covered metal stents, offer additional benefits like preventing tumor ingrowth and migration. Furthermore, the development of biodegradable and drug-eluting metal stents is further driving their adoption.
   
• Additionally, metal stents, especially self-expanding metallic stents (SEMS), are widely used to treat malignant biliary obstructions caused by cancers such as pancreatic and cholangiocarcinoma. Their longer patency period and reduced need for replacements make them a cost-effective solution for palliative care.
   

Based on application, the biliary stents market is classified into bilio-pancreatic leakages, pancreatic cancer, benign biliary structures, gallstones, and other applications. The gallstones segment accounted for USD 238.8 million in market revenue in 2024 and is anticipated to grow at a CAGR of 5.4% between the 2025 – 2034 period.
 

• Gallstones are a common biliary condition worldwide, with higher incidence rates in developed regions due to dietary patterns, obesity, and sedentary lifestyles. The growing number of cases is leading to an increased need for biliary stents to manage obstructions and complications effectively.
   
• Biliary stents are increasingly integrated into advanced treatment protocols involving ERCP. ERCP with stent placement is commonly performed to restore bile flow and prevent infection or further complications from gallstones.
   
• Moreover, improved diagnostic tools such as ultrasonography and MRI have led to the earlier detection of gallstones and related complications. Early diagnosis has increased the use of biliary stents as a preventive or therapeutic measure in managing gallstone-related obstructions.
   

Based on end use, the biliary stents market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and other end-users. The hospitals segment dominated the market in 2024 and is anticipated to reach USD 543.4 million by the end of the forecast period.
 

• Hospitals have the necessary infrastructure and expertise to handle complex procedures such as ERCP and PTC, which are used to diagnose and treat biliary conditions. These advanced imaging and intervention techniques are essential for the proper placement of biliary stents.
   
• Due to advancements in stent materials, design, and placement techniques, hospitals can offer better outcomes and more effective management of biliary disorders, driving the demand for biliary stents.
   
• Furthermore, as new stent technologies receive regulatory approvals and are recommended in clinical guidelines, hospitals are more likely to adopt these products. Many hospitals follow the latest clinical guidelines, which increasingly advocate the use of newer, more effective stents, such as biodegradable and drug-eluting types, for managing biliary obstructions. This ensures that hospitals are equipped with the latest technologies and treatments, further boosting the demand for biliary stents in these settings.
   

The U.S. biliary stents market accounted for USD 147.2 million market revenue in 2024 and is anticipated to grow at a CAGR of 4.9% between the 2025 – 2034 period.
 

• The U.S. is experiencing a rise in the incidence of biliary diseases, directly contributing to the demand for biliary stents. Conditions such as biliary obstructions, gallstones, cholangitis, and bile duct cancers (including pancreatic cancer and cholangiocarcinoma) are common in the country.
   
• Additionally, insurance coverage, including Medicare and Medicaid, plays a significant role in increasing access to procedures like biliary stent placement in the U.S. As biliary stents are considered a standard treatment for managing biliary obstructions, insurance companies typically cover the costs, making the procedure more accessible to a broader population.
   

The France biliary stents market is projected to grow remarkably in the coming years.
 

• Biliary stents are commonly used to manage malignant biliary obstructions caused by cancers such as pancreatic cancer and cholangiocarcinoma. France has seen an increase in cancer cases due to factors like lifestyle changes, smoking, and an aging population. As a result, the demand for biliary stents for palliative care and symptom management in cancer patients has grown considerably.
   
• In addition, the demand for biliary stents in France has been rising due to a combination of healthcare advancements, demographic changes, and the increasing prevalence of biliary and hepatobiliary diseases.
   

Japan holds a dominant position in the Asia Pacific biliary stents market.
 

• Japan has one of the most rapidly aging populations in the world, with over 28% of its population aged 65 years or older. This demographic shift has led to a higher prevalence of age-related diseases, including bile duct cancer, gallstones, and chronic pancreatitis. Older adults are more susceptible to biliary obstructions, which increases the need for interventions like biliary stents to manage these conditions effectively.
   
• Additionally, Japanese hospitals and healthcare providers are increasingly performing minimally invasive procedures for biliary stent placement. These procedures are less invasive than traditional surgeries and align with Japan's focus on patient-centered care. The growing preference for these techniques is driving the use of biliary stents in the country.
   

Biliary Stents Market Share

Key players in the market focus on innovation, portfolio expansion, and strategic collaborations to strengthen their market position. They are investing in research and development to introduce advanced stents, such as drug-eluting and fully covered metallic stents, which offer improved patency and reduced complications. Companies are also emphasizing minimally invasive techniques and biodegradable materials to align with patient-centric healthcare trends. Additionally, partnerships with hospitals, distribution network enhancements, and regional expansions in emerging markets are central to their strategies.
 

Biliary Stents Market Companies

Prominent players operating in the biliary stents industry include:

• B Braun
• Becton, Dickinson & Company
• Boston Scientific
• Cardinal Health
• CONMED Corporation
• Cook Group
• ENDO-FLEX GmbH
• M.I Tech
• Mediwood
• Medtronic
• Merit Medical System
• Olympus Corporation
• S & G Biotech
• TAEWOONG
   

Biliary Stents Industry News:

• In July 2024, CGBIO announced that it has received product approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for its ARISTENT biliary stents. The product is gaining traction in the Japanese market and the company is accelerating for global expansion. This product approval will enhance company's portfolio and market reach.
   

The biliary stents market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Market, By Type

• Metal stents
• Polymer stents

Market, By Application

• Gallstones
• Pancreatic cancer
• Bilio-pancreatic leakages
• Benign biliary strictures
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Specialty clinics
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE